Table 3.
Median survival after cTACE and DEB-TACE
| Median survival (months after initial TACE) | cTACE | DEB-TACE | Ratio | 95% CI of ratio |
|---|---|---|---|---|
| Overall | 10.8 | 9.2 | 1.170 | (0.5054–2.707) |
| Multinodular tumor burden | 15.1 | 10.7 | 1.410 | (0.4612–4.310) |
| Bilobar tumor burden | 15.4 | 13.0 | 1.158 | (0.3822–3.675) |
| Child-Pugh class A | 22.1 | 10.7 | 2.061 | (0.6540–6.492) |
| Not superselective procedure | 10.8 | 10.7 | 1.007 | (0.3778–2.682) |
Abbreviations: cTACE, conventional transarterial chemoembolization; DEB-TACE, transarterial chemoembolization with drug-eluting beads; TACE, transarterial chemoembolization; CI, confidence interval.